Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer

Establishes New Clinical Advisory Board of Leading Oncology Experts

Cambridge, UK, 1 April 2019. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announces the appointment of Ian Smith, M.D., as Chief Medical Officer. Dr. Smith will assume responsibility for leading Artios’s overall preclinical and clinical development strategy, regulatory, and medical activities. He will work in tandem with and report directly to Niall Martin, Chief Executive Officer, and join the company’s executive leadership team.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH